Cite
Dosing depending on SIRT3 activity attenuates doxorubicin-induced cardiotoxicity via elevated tolerance against mitochondrial dysfunction and oxidative stress.
MLA
Yang, Na, et al. “Dosing Depending on SIRT3 Activity Attenuates Doxorubicin-Induced Cardiotoxicity via Elevated Tolerance against Mitochondrial Dysfunction and Oxidative Stress.” Biochemical & Biophysical Research Communications, vol. 517, no. 1, Sept. 2019, pp. 111–17. EBSCOhost, https://doi.org/10.1016/j.bbrc.2019.07.029.
APA
Yang, N., Ma, H., Jiang, Z., Niu, L., Zhang, X., Liu, Y., Wang, Y., Cheng, S., Deng, Y., Qi, H., & Wang, Z. (2019). Dosing depending on SIRT3 activity attenuates doxorubicin-induced cardiotoxicity via elevated tolerance against mitochondrial dysfunction and oxidative stress. Biochemical & Biophysical Research Communications, 517(1), 111–117. https://doi.org/10.1016/j.bbrc.2019.07.029
Chicago
Yang, Na, Haoyue Ma, Zhou Jiang, Lihong Niu, Xinshang Zhang, Yanyou Liu, Yuhui Wang, et al. 2019. “Dosing Depending on SIRT3 Activity Attenuates Doxorubicin-Induced Cardiotoxicity via Elevated Tolerance against Mitochondrial Dysfunction and Oxidative Stress.” Biochemical & Biophysical Research Communications 517 (1): 111–17. doi:10.1016/j.bbrc.2019.07.029.